Back
Macrogenics Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
60
MGNX
Macrogenics
Last Price:
3.40
Seasonality Move:
16.69%
Buy
53
APLS
Apellis Pharmaceuticals
Last Price:
32.62
Seasonality Move:
15.03%
Buy
60
Macrogenics (MGNX)
is a Buy
Is Macrogenics a Buy, Sell or Hold?
- The current Macrogenics [MGNX] share price is $3.40. The Score for MGNX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- MGNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.63. The Score for APLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MGNX Stock Price Chart
What is Macrogenics's stock price today?
-
The Macrogenics share price today is $3.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.
MGNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 43.09 | Sell |
Chaikin Money Flow: | 290365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.33 - 4.05) | Sell |
Bollinger Bands (100): | (3.19 - 4.45) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 64.76 | Buy |
Chaikin Money Flow: | 660541 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.84 - 29.98) | Buy |
Bollinger Bands (100): | (28.48 - 38.54) | Sell |
MGNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.37 | Buy |
20-day SMA: | 3.72 | Sell |
50-day SMA: | 3.63 | Sell |
200-day SMA: | 7.88 | Sell |
8-day EMA: | 3.43 | Sell |
20-day EMA: | 3.6 | Sell |
50-day EMA: | 3.72 | Sell |
200-day EMA: | 5.87 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29 | Buy |
20-day SMA: | 28.71 | Buy |
50-day SMA: | 28.92 | Buy |
200-day SMA: | 42 | Sell |
8-day EMA: | 30 | Buy |
20-day EMA: | 29.06 | Buy |
50-day EMA: | 30.07 | Buy |
200-day EMA: | 39.32 | Sell |
Macrogenics Earnings Growth & MGNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.79 per share, and a decrease next year of $1.12 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.
Macrogenics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |